About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, March 6th, 2018

The QualityStocks
Daily Stock List


Eco Science Solutions, Inc. (ESSI)

Wall Street Mover, ThePUMPTracker, DSR News, Real Pennies, Promotion Stock Secrets, TopPennyStockMovers, Wallstreetlivechat, and Pumps and Dumps reported earlier on Eco Science Solutions, Inc. (ESSI), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Eco Science Solutions, Inc. is an eco-technology Company with its corporate headquarters in Makawao, Hawaii. It provides solutions to the multi-billion-dollar health, wellness, and alternative medicine industry. Eco Science Solutions develops technical solutions - from enterprise software solutions, to consumer applications (apps) for daily use. These solutions energize enthusiasts in their pursuit and enjoyment of building eco-friendly businesses and living healthy lifestyles. Eco Science Solutions’ shares trade on the OTC Markets Group’s OTCQB.

Eco Science Solutions’ key services cover localized communications between consumers and business operators, social networking with like-minded enthusiasts, rich educational content, e-commerce, and fast delivery of products. These all cater to the health-and-wellness lifestyle.

The Company’s brands include Herbo, Fitrix, and pHion Balance. The Herbo app assists consumers in finding products and services that support the intake of alternative medicines for a more naturopathic lifestyle. Herbo has a database of greater than 14,000 alternative medicine locations and delivery services, doctors who provide evaluations, and local shops that sell relevant product.

The Fitrix app is a strong and flexible companion. Fitrix assists users’ in keeping track of their day-to-day fitness routines, dietary habits, and alternative medicine intake. Fitrix users can measure and track anything and everything concerning their health and wellness.

The Company’s pHion Balance underwent development to create nutritional supplements, which support and promote a healthy lifestyle. pHion Balance is centered on developing nutritional supplements that take the guesswork out of supplementing the body in the healthiest way.

Eco Science Solutions will continue to make investments in e-commerce and mobile applications that facilitate B2C (Business-to-Consumer) e-commerce opportunities.

Last year, Eco Science Solutions' main projects focused on continued consumer and enterprise technology investment; continued product formulation and inventory build for distribution; and strategic acquisitions, which provide an accelerated time-frame to obtain market share.

In May of 2017, the Company announced that it signed a Sponsorship, Content Development, and Licensing agreement with Roaring Lion Tours, Inc. Roaring Lion Tours develops inspirational and educational content that further promotes what it believes are the benefits of medical marijuana. This agreement is to develop unique educational content that brings awareness and education to the alternative medicine category.

Eco Science Solutions, Inc. (ESSI), closed Tuesday's trading session at $0.14, down 6.67%, on 27,192 volume with 12 trades. The average volume for the last 60 days is 39,241 and the stock's 52-week low/high is $0.001/$3.55.

Artemis Therapeutics, Inc. (ATMS)

Zacks, InvestorsHub, Stockhouse, NASDAQ.com, OTC Markets and Simply Wall St reported on Artemis Therapeutics, Inc. (ATMS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A clinical-stage biopharmaceutical company, Artemis Therapeutics, Inc. concentrates on the development of new therapies for the treatment and prevention of severe and life-threatening infectious diseases. Its lead product candidate is Artemisone. This is an innovative, synthetic artemisinin derivative with potent anti-viral and anti-parasitic properties. Listed on the OTCQB, Artemis Therapeutics has its corporate office in New York, New York.

Artemisone is a best-in-class artemisinin. It has been studied in a Phase 2 clinical trial for the treatment of malaria (p. falciparum). At present, Artemisone is undergoing in vitro evaluation for its activity against human cytomegalovirus (CMV). This includes transplant CMV and congenital CMV.

Artemisinin and its derivatives including artesunate, artemether, arteeter and dihydro-atemisinin (DHA) have for numerous years been the foundation of treatment of uncomplicated p. falciparum malaria. Phase II clinical data has shown Artemisone to be an efficacious treatment for p. falciparum malaria infection when dosed over a 2-day or 3-day course, akin to or shorter than other available malaria treatments.

Bayer originally developed Artemisinin. Bayer exited for strategic reasons, before field reports of artemisinin resistance.

Artemisinin Combination Therapy (ACT) is the basis of malaria treatment globally. Artemisone is a novel member of the artemisinin class. Positive attributes include thermal stability, low neurotoxicity, and more.

Other potential anti-parasitic and anti-viral indications are undergoing exploration in pre-clinical testing. Two more programs will be named in the first half of this year.

Artemis Therapeutics has licensed pre-clinical data from Hadasit Medical Research Services and Development Ltd. in HCMV and clinical data from Hong Kong University of Science and Technology R and D Corporation Limited (RDC) in the treatment of Malaria.

This past November, Artemis Therapeutics announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for Artemisone for the treatment of malaria. The Company is now qualified to receive substantial benefits throughout its orphan drug development program. This includes more frequent FDA interactions, protocol assistance, as well as tax credits for clinical research expenses.

Furthermore, in November, the Company announced the recent issuance by the European Patent Office (EPO) of European Patent No. 2839803 entitled “Methods and Compositions for Treating Viral Infections” encompassing Artemisone, now in development for the treatment of malaria and cytomegalovirus (CMV).

This European patent will provide intellectual property (IP) protection for the Artemisone program in important markets. The expectation is that this patent will expire no earlier than 2033.

Artemis Therapeutics, Inc. (ATMS), closed Tuesday's trading session at $1.38, down 8.00%, on 200 volume with 1 trade. The average volume for the last 60 days is 217 and the stock's 52-week low/high is $0.60/$1.70.

Alacer Gold Corp. (ALIAF)

MarketWatch, TradingView, Investing, Silverstocker, InvestorPlace, GoldStockData, NorthernMiner, 4-Traders, Investopedia, OTC Markets, The Street, MiningFeeds, Information Vine, and Penny Stock Tweets reported on Alacer Gold Corp. (ALIAF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Alacer Gold Corp. is a foremost intermediate gold mining company headquartered in Denver, Colorado. The Company has an 80 percent interest in the world-class Çöpler Gold Mine in Turkey operated by Anagold Madencilik Sanayi ve Ticaret A.S. The remaining 20 percent is owned by Lidya Madencilik Sanayi ve Ticaret A.S. Alacer Gold is pursuing initiatives to enhance value beyond the present mine plan. Alacer Gold’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s main emphasis is to take advantage of its cornerstone Çöpler Mine and strong balance sheet to maximize portfolio value, maximize free cash flow, and minimize project risk. The Çöpler Mine is located in east-central Turkey in the Erzincan Province.

The Çöpler Gold Mine produced 119,036 ounces of gold during 2016. Çöpler has considerable Probable Reserves of 4 million recoverable ounces and Measured and Indicated Resources of 6 million ounces of contained gold. These provide the basis for Çöpler’s 20 year mine life.

At present, the Mine is an open-pit, heap-leach operation producing low-cost gold from oxide ore. Over the life of the present heap-leach project, roughly 76 percent of the gold contained in the oxide ore is expected to be recovered.

In May of 2016, Alacer Gold’s Board of Directors approved full construction of the Sulfide Project at the Çöpler Gold Mine, with first gold pour expected in Q3 of 2018. The Çöpler orebody contains refractory sulfide ore. This necessitates a different processing solution than heap-leaching to extract the gold.

The Sulfide Project construction is over 75 percent complete, under budget, and on course for first gold production in Q3 2018. The expectation is that the Sulfide Project will deliver long-term growth with strong financial returns and adds 20 years of production at the Çöpler Gold Mine. The Sulfide Project will bring Çöpler’s remaining life-of-mine gold production to greater than 2 million ounces at All-in Sustaining Costs averaging $645 per ounce.

This week, Alacer Gold announced full-year 2017 production results, unaudited full-year cost results, and 2018 production and cost guidance.

Mr. Rod Antal, President and Chief Executive Officer of Alacer Gold, stated, “I am pleased to report that we produced 168,1631 ounces of gold at unaudited All-in Sustaining Costs (AISC) of $685 per ounce in 2017, meeting our original production and beating AISC cost guidance for the year. The production initiatives generated through our operational excellence program were very successful, delivering 64,542 ounces in the fourth quarter, making it the strongest quarter of the year… 2018 production guidance is 120,000 to 190,000 ounces from Çöpler oxides and sulfides. We also expect initial mining at a new oxide deposit, Çakmaktepe, later this year.”

Alacer Gold Corp. (ALIAF), closed Tuesday's trading session at $1.68, up 2.44%, on 1,000 volume with 3 trades. The average volume for the last 60 days is 17,659 and the stock's 52-week low/high is $1.42/$2.22.

AmeriCann, Inc. (ACAN)

Real Pennies, TopPennyStockMovers, Promotion Stock Secrets, Cannabis Financial Network News, OTC Markets Group, SmallCapVoice, and TheMicrocapNews reported on AmeriCann, Inc. (ACAN), and we also report on the Company, here at the QualityStocks Daily Newsletter.

AmeriCann, Inc. is developing sustainable, state-of-the-art medical cannabis cultivation properties. The Company is a national leader of sustainable cultivation and processing infrastructure for the medical marijuana industry. It designs, builds, and and owns efficient cultivation and processing facilities to produce medical cannabis. It is developing projects across the country in regulated markets through the “Preferred Partner Program”. An Agricultural Technology Company, AmeriCann has its corporate headquarters in Denver, Colorado.

AmeriCann is developing a 53-acre property in Massachusetts as the Massachusetts Medical Cannabis Center (the MMCC). The MMCC has approval for 1 million square feet. The expectation is that it will be one of the most technologically advanced cultivation facilities in the nation.

AmeriCann’s mission is to serve medical cannabis patients through providing facilities designed and constructed to produce high quality, consistent medicine, cultivated and processed in a controlled, secure, and sustainable environment. The Company identifies, acquires, and develops real estate particularly suited for cannabis operations. It finances real estate development. Moreover, it provides necessary venture capital to developing cannabis enterprises.

AmeriCann announced in September of 2017 that Coastal Compassion, Inc. (CCI), its Preferred Partner in Massachusetts, received a Final Certificate of Registration from the Department of Public Health. CCI is one of a limited number of vertically integrated companies approved to cultivate, process and ultimately dispense medical cannabis in the Massachusetts Medical-Use of Marijuana program.

With the Final Certificate of Registration, CCI has all the approvals to commence cultivation in its fully-constructed Registered Marijuana Dispensary (RMD) in Fairhaven, Massachusetts. The Fairhaven RMD will house CCI's first cultivation and processing operations and a permanent retail dispensary location.

AmeriCann has agreements with Coastal Compassion to lease 100 percent of the first phase of MMCC that will consist of a 30,000 square foot greenhouse, laboratory, as well as research center.

This past January, AmeriCann provided its analysis of Attorney General Jeffrey Sessions’ memo issued on January 5, 2018 concerning federal marijuana enforcement.

Mr. Tim Keogh, AmeriCann’s President and Chief Executive Officer, stated, "Cannabis has been regulated successfully at the state level since 1996. We expected the new leadership within the Department of Justice to implement their own policies. However, we don't anticipate that the change in policies at the DOJ will significantly impact patients, consumers or businesses that comply with state regulations."

AmeriCann, Inc. (ACAN), closed Tuesday's trading session at $2.474, down 1.83%, on 35,006 volume with 90 trades. The average volume for the last 60 days is 108,289 and the stock's 52-week low/high is $1.11/$5.35.

Equinox Gold Corp. (LWLCF)

OTC Markets, The Street, Metals Channel, Bzweekly, InvestorsHub, Stockwatch, 4-Traders, MarketWatch, Stockhouse, Barchart, MINING, Private Capital Journal, Morningstar, YCharts, and Investorx.ca reported on Equinox Gold Corp. (LWLCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Equinox Gold Corp. engages in the acquisition, exploration, and development of mineral deposits. The Company has a multi-million-ounce gold resource base and near-term and growing gold production from two past-producing mines in Brazil and California. It also has a long-term growth platform with a varied portfolio of gold and copper assets in North and South America.

Established in 2007, the Company previously went by the name Trek Mining, Inc. It changed its name to Equinox Gold Corp. this past December. Equinox Gold has its corporate headquarters in Vancouver, British Columbia.

The Company has a growth pipeline of gold and copper projects. Furthermore, production from its Aurizona Gold Mine is targeted for year-end 2018. Moreover, there is the potential to considerably increase gold production by 2020 via development of the Castle Mountain Gold Mine.

The Aurizona Gold Mine is in northeastern Brazil. This mine will be a low-cost, open-pit gold mine. The estimation is that average annual production will be 136,000 ounces annually.

The Castle Mountain Gold Mine (100 percent-owned) is in the State of California. The production potential is 300,000-plus ounces annually. Equinox Gold is completing a Prefeasibility Study for Castle Mountain. Its goal is restarting production.

Equinox Gold’s’ other projects include Koricancha, which is an operational ore processing facility in Peru. Projects also include Elk Gold, which is a high-grade past-producing gold project in British Columbia. Projects additionally include Warintza, a Cu-Mo porphyry project in central Ecuador; Ricardo, a Cu-Mo porphyry project in northern Chile; and La Verde, a Cu-Ag-Au porphyry project in Mexico.

Last month, Equinox Gold announced the discovery of significant gold mineralization at the East Ridge target, peripheral to the present resource pit at its Castle Mountain Gold Mine in California. A channel sampling program encompassing a portion of the East Ridge target identified extensive, earlier unrecognized gold mineralization on surface corroborated by three of the best drill results from the Q4-2017 exploration program.

Equinox completed 27 holes totalling 9,230 m during Q4 2017. It obtained additional positive results from drilling designed to test the margins of the current modeled resource pit and below the historical open pits (JSLA, Jumbo and Oro Belle). Equinox’s intention is to drill greater than 30,000 m later this year.

Yesterday, Equinox Gold announced it awarded the mining contract for its Aurizona Gold Mine in Brazil to U&M Mineração e Construção S/A (U&M). At present, U&M is mobilizing the site to begin mining activities this month. U&M is a Brazilian company. It has over four decades of mining contract experience.

Equinox Gold Corp. (LWLCF), closed Tuesday's trading session at $0.882, down 0.90%, on 111,007 volume with 59 trades. The average volume for the last 60 days is 100,549 and the stock's 52-week low/high is $0.6873/$1.49.

MYnd Analytics, Inc. (MYND)

Stock Twits, Zacks, Equity Clock, NASDAQ, Capital Cube, BioSpace, MarketWatch, Simply Wall St, 4-Traders, Barchart, OTC Markets, The Street, BusinessInsider, Bzweekly, GuruFocus, and Marketbeat reported on MYnd Analytics, Inc. (MYND), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

MYnd Analytics, Inc. is a predictive medicine company headquartered in Mission Viejo, California. Mynd brings objective physical findings to psychiatric treatment to lessen trial and error treatment in mental health. The Company provides a unique set of reference data and analytic tools for clinicians and researchers in psychiatry. Mynd Analytics lists on the NasdaqCM.

MYnd Analytics has its Psychiatric EEG Evaluation Registry, or PEER Online®. The goal of PEER Online is to provide objective, personalized data to assist physicians in the selection of appropriate medications.

PEER Online is a cloud-based platform. It is a registry and reporting platform. It enables medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG).

Mynd Analytics has its MYnd Analytics Center. This Center provides a convenient, relaxing, and welcoming environment for one to receive their EEG and PEER Report™. The EEG is performed on-site at the MYnd Analytics Center. It usually takes less than one hour. The EEG and PEER Report are available by appointment only.

PEER underwent development by physicians to provide objective information regarding medication response for similar patients. PEER combines a "crowdsourced" secure physician outcome registry with electroencephalogram (EEG), an accepted, well-normed test of brain function. EEG is a completely painless, non-invasive test. It records one’s brain’s electrical activity.

Based on MYnd Analytics original physician-developed database, there are presently more than 39,000 outcomes for over 11,000 unique patients in the PEER registry.

Essentially, physicians built this platform, they contribute new outcomes as they see patients, and they will never be finished building the registry. Physicians who use PEER reduce trial and error prescribing.

Recent highlights for MYnd Analytics include completing the acquisition of revenue-generating Arcadian Telepsychiatry Services. The anticipation is that this acquisition will produce fast growth and benefits from cross-selling going forward.

Recent highlights for the Company also include the first patient enrolled in a 600-patient paid pilot with Horizon Healthcare Services, Inc. This is to improve patient care over trial and error medication management and to lessen total costs of care. Also, MYnd ended the Fiscal Year with a strong balance sheet; more than $5 million of cash.

MYnd Analytics announced last month that it received its first notice of patent allowance in Canada on its neuromodulation platform for predicting patients likely to respond to Transcranial Magnetic Stimulation (TMS). The patent is entitled “Method for Assessing the Susceptibility of a Human Individual Suffering from a Psychiatric or Neurological Disorder to Neuromodulation Treatment.”

It provides patent protection through 2029. In addition, MYnd has applied for patents in the U.S. It expects these will be awarded later in 2018.

Recently, Advanzeon Solutions, Inc. (CHCR) and MYnd Analytics announced that Advanzeon’s wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. (PVMS), and MYnd’s wholly-owned subsidiary, Arcadian Telepsychiatry Services, entered into an Agreement, expanding PVMS’ and Arcadian’s collaboration.

PVMS, by way of its SMS Sleep Apnea Program, is a national leader in the screening, testing and treating (when indicated) of sleep apnea. Its area of expertise presently centers on the commercial trucking industry and encompasses all 50 States.

MYnd Analytics, Inc. (MYND), closed Tuesday's trading session at $2.20, down 0.45%, on 54,331 volume with 147 trades. The average volume for the last 60 days is 10,553 and the stock's 52-week low/high is $1.7892/$7.95.

Isodiol International, Inc. (ISOLF)

OTC Markets, Investopedia, Stockhouse, InvestorsHub, and Wealth Daily reported on Isodiol International, Inc. (ISOLF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

An international CBD innovator, Isodiol International, Inc. specializes in the development of pharmaceutical and wellness products. Its growth strategy includes the development of over-the-counter (OTC) and pharmaceutical drugs, and expanding its phytoceutical portfolio. Isodiol is continuing worldwide expansion into Latin America, Asia, and Europe. Isodiol International is based in Vancouver, British Columbia.

The Company is the market leader in pharmaceutical grade phytochemical compounds. In addition, it is the industry leader in the manufacturing and development of phytoceutical consumer products. Be Trū Wellness (Be Tru) is a wholly-owned subsidiary of Isodiol International.

Isodiol International produces raw ingredients, consumer packaged goods including dietary supplements, food and beverages, skin care, and pharmaceutical products for the global healthcare market. Concerning raw ingredients, the Company develops natural phytoceutical derivatives and delivery technologies.

Regarding consumer products, Isodiol develops its own family of product brands for retail sale. Additionally, the Company develops white label products and brands for wholesale customers. Concerning pharmaceuticals, Isodiol supplies raw phytoceutical ingredients.

Isodiol International Inc announced in November 2017 the U.S. sales launch of ImmunAG™. This product is the market’s first non-cannabis cannabidiol (CBD) product derived from the hops plant. This is a time-released tablet. The ImmunAG tablet does not dissolve in the stomach. It dissolves in the lower intestine, thus creating greater bioactivity.

Isodiol International has acquired international licensing rights for IsoDerm™ and five other proprietary pharmaceutical compounds to be delivered by the patented Direct Effects Technology™. This is a back of the neck delivery system from its developer Dr. Ronald Aung-Din, MD.

Isodiol International announced this past November that it entered into a definitive agreement in connection with its earlier announced Letter of Intent (LOI) to acquire Bradley’s Bioscience, Inc. Bradley’s is a top manufacturer and distributer of hemp oil and nicotine e-liquids.

Isodiol International has also entered into a binding agreement to acquire 100 percent of C3 Global Biosciences (C3GBS). C3GBS is a cause driven organization. Its devotion is to developing sustainable health solutions through the advancement of cannabis science.
Recently, Isodiol International announced that it signed a Letter of Intent (LOI) to acquire 100 percent of the CBD assets of Green Island Naturals. Green Island Naturals is a formulator, marketer, and seller of a proprietary line of hemp extract products distributed in retail and online outlets in Canada.

In February, Isodiol International announced that it entered into a Definitive Agreement to acquire 100 percent of Canadian National Pharma Group, Inc. (CN Pharma). Isodiol announced on Dec. 6, 2017 the agreement to acquire an initial stake representing 25 percent equity of CN Pharma. It is now purchasing the remaining 75 percent equity. It will establish CN Pharma as a wholly-owned subsidiary. CN Pharma is a pharmaceutical manufacturing business.

Last week, Isodiol International reported unaudited Q3 Revenues for the period ended December 31, 2017 of $5.89 million CDN for a Net Operational profit of $202,254 CDN. Versus Fiscal Q2 revenues, Q3 represents a 16 percent increase. Isodiol attributes the growth and profit increase to increased distribution, decreased manufacturing costs, portfolio diversification, and also the continued integration of wholly-owned subsidiaries.

Isodiol International, Inc. (ISOLF), closed Tuesday's trading session at $0.905, up 3.52%, on 138,795 volume with 71 trades. The average volume for the last 60 days is 293,332 and the stock's 52-week low/high is $0.0513/$1.69.

Trevali Mining Corporation (TREVF)

Streetwise Reports, MarketWatch, OTC Markets, InvestorsHub, Stockhouse, InvestingNews.com, StreetInsider, JuniorMiningNetwork, NorthernMiner, TipRanks, YCharts, Marketwired, Capital Cube, Mining, GuruFocus, Investopedia, Stockwatch, ResourceWorld, Stockinvest.us, and Emerging Growth reported on Trevali Mining Corporation (TREVF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Trevali Mining Corporation is a zinc-focused, base metals company headquartered in Vancouver, British Columbia. Its strategy includes attaining mid-tier Mining Company status via a combination of organic growth and unique deals and strategic alliances. The Company previously went by the name Trevali Resources Corp. It changed its name to Trevali Mining Corporation in April of 2011. Incorporated in 1964, Trevali Mining lists on the OTC Markets Group’s OTCQB.

The Company is focusing exploration activities in highly prospective, under-explored terrain in nations and regions that offer security of tenure and support mineral deposit development. Trevali Mining is a pure-play producer with industry-leading leverage to zinc with 80-85 percent of revenue coming from zinc production.

Production has risen annually for five straight years. Resources at all mines remain open for expansion with exploration drill programs continuing. Glencore is a cornerstone strategic shareholder - 25.6 percent.

Trevali Mining has four mines. These are the wholly-owned Santander mine in Peru, the wholly-owned Caribou mine in the Bathurst Mining Camp of northern New Brunswick, Trevali Mining’s 80 percent owned Rosh Pinah mine in Namibia, and its 90 percent owned Perkoa mine in Burkina Faso.

In addition, Trevali Mining owns the Halfmile and Stratmat base metal deposits in the Province of New Brunswick. At present, these are undergoing a Preliminary Economic Assessment (PEA) reviewing their potential development.

Last month, Trevali Mining announced the latest results of its 2017 exploration campaign at the Caribou Zinc Mine in the Bathurst Mining Camp of New Brunswick. Directional exploration drilling defined a significant body of massive sulphide mineralization containing major zinc-rich polymetallic intervals. As presently defined, the zone is centered roughly 350 meters from the currently defined deposit. Moreover, it remains open for expansion.

Also concerning the Bathurst Mining Camp, Trevali Mining acquired five strategic mineral claim blocks from partner Glencore subject to a 2 percent NSR (Net Smelter Return) for any future production for a total of 3,520 ha of area, expanding Trevali's total land holdings to 11,380 ha in the Camp.

This week, Trevali Mining reported preliminary consolidated Q4 2017 production of 104.8-million payable pounds of zinc, 13.5-million payable pounds of lead and 396,899 payable ounces of silver. Preliminary 2017 annual production was 177.4-million payable pounds of zinc, 45.8-million payable pounds of lead and 1,561,508 payable ounces of silver.

The Company had record overall consolidated Q4-2017 and 2017 annual zinc and lead production. It had its highest annual zinc production, mill throughput and mine output at the Perkoa mine.

Trevali Mining had record quarterly metal production, mine output and mill throughput at the Caribou mine. The continuing transition to owner mining has enabled productivity improvements.

The Rosh Pinah mill re-grind circuit completed in Q4. It is anticipated to increase recoveries and increase concentrate quality. The Company states that the integration of the Perkoa and Rosh Pinah mines, acquired from Glencore on August 31, 2017, continues to progress well.

Trevali Mining Corporation (TREVF), closed Tuesday's trading session at $1.09, up 2.74%, on 35,384 volume with 19 trades. The average volume for the last 60 days is 58,316 and the stock's 52-week low/high is $0.757/$1.37.

Butler National Corp. (BUKS)

Zacks, Marketbeat, MarketWatch, and Feed Blitz reported previously on Butler National Corp. (BUKS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Butler National Corp. is a top manufacturer and provider of support systems for commercial and military aircraft. The Company is also a recognized provider of management services in different business groups. These include the gaming industry. Butler is a leader in the growing global market for aircraft structural modification, maintenance, repair and overhaul (MRO). Listed on the OTCQB, Butler National is based in Olathe, Kansas.

The Company formed in 1968 through the merger of an aviation research firm owned by the Butler family and National Connector Corporation. Butler National combined resources of the two companies to develop one of the first commercial Area Navigation Systems (RNAV) used for airplane navigation.

Butler’s subsidiaries include Avcon Industries, Inc.; Butler Avionics, Inc.; BCS Design, Inc.; Boot Hill Casino & Resort; The Stables Casino; and Butler National-Tempe. Avcon Industries provides aircraft owners and operators with products and services designed to satisfy special mission requirements, or enhance the utility of business jets and turboprops.

Butler National’s Aerospace segment concentrates on the manufacturing of support systems for "Classic" commercial and military aircraft. This includes the Butler National TSD for the Boeing 737 and 747 Classic aircraft. In addition, this segment concentrates on switching equipment for Boeing McDonnell Douglas Aircraft, weapon control systems for Boeing Helicopter, and performance enhancement structural modifications for Learjet, Cessna, Dassault, and Beechcraft business aircraft.

Boot Hill Casino & Resort is in Dodge City, Kansas. It is home to the first state owned and operated casino gaming in Kansas. The Stables Casino is a Class III gaming establishment in Miami, Oklahoma. The Miami Tribe and the Modoc Tribe owns it.

Butler National-Tempe operates in the Defense Contracting & Electronics industry. Butler’s Management Services segment includes temporary employee services, gaming services, and administrative management services. Butler Avionics’ services include new installations and retrofits, to avionics, autopilot, instruments, as well as radar troubleshooting and repair. Furthermore, BCS Design is a full-service architectural firm.

Last month, Butler Avionics, the subsidiary of Butler National, announced European Aviation Safety Agency (EASA) Supplemental Type Certificate (STC) approval of the Butler National ADS-B (Out) avionics solution in the Learjet Model 35, 35A, 36, 36A and Lear 60.

The EASA approved STC modification, STC Number 10063974, provides an independent ADS-B(Out) system with the installation of the Garmin GTX 3000 Transponders, the GDL 88 (Dual Band UAT/1090 Receiver with WAAS GPS Sensor) and the Flight Stream 210 Bluetooth Transmitter in the Learjet 35, 35A, 36, 36A and Learjet Model 60 airplanes. This system provides a seamless interface to most TCAS II equipment. It does so while providing the crew optional access to ADS-B(In) when within the U.S.

In addition, in December, Butler National announced its financial results for Q2 fiscal 2018 ended October 31, 2017. Q2 fiscal 2018 resulted in a Net Income of $84,000 versus a Net Income of $519,000 in Q2 fiscal 2017.

The Company stated: “Revenue decreased 13 percent to $11.2 million in the three months ended October 31, 2017, as compared to $12.8 million in the three months ended October 31, 2016. The decrease in revenue reflects a decrease in Aerospace Products revenue (down 25 percent) and a decrease of 5 percent in Professional Services revenue. Butler National Corporation continues to drive growth in international markets and through the development of new supplemental type certificates. This includes significant efforts in South America, Europe, Africa, and Asia.”

Butler National Corp. (BUKS), closed Tuesday's trading session at $0.26, up 8.33%, on 8,500 volume with 3 trades. The average volume for the last 60 days is 35,625 and the stock's 52-week low/high is $0.171/$0.4799.

Strategic Environmental & Energy Resources, Inc. (SENR)

Streetwise Reports and Marketbeat reported on Strategic Environmental & Energy Resources, Inc. (SENR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Strategic Environmental & Energy Resources, Inc. (SENR) is a provider of environmental, renewable fuels and industrial waste stream management services. It has three wholly-owned operating subsidiaries. These are REGS, LLC; MV Technologies, LLC, and SEER Environmental Materials, LLC. SENR works for either destroying/minimizing hazardous waste streams more safely and at lesser cost than any competitive alternative, and/or processing the waste for use as a renewable fuel for the benefit of customers and the environment. SENR has its corporate office in Golden, Colorado.

The Company is strategically shifting to a dedicated environmental technology enterprise. It also has two majority-owned subsidiaries. These are Paragon Waste Solutions, LLC; and ReaCH4biogas (Reach).

SENR provides environmental, renewable fuels, and industrial waste stream management services to oil producers and refiners, railcar operators, industrial and manufacturing companies, medical facilities, government agencies, universities and environmental consulting firms. Its customers engage the Company to manage initiatives ranging from improving operating efficiencies to EPA (Environmental Protection Agency) compliance to creation of renewable fuels.

Fundamentally, SENR identifies, secures, and commercializes patented and proprietary environmental clean technologies in several multibillion dollar sectors. These sectors include oil & gas, renewable fuels, and all types of waste management, solid and gaseous.

Concerning Waste Destruction, the Company’s Paragon Waste Solutions is at the technological front line of the waste management and destruction industry. Paragon Waste Solutions’ patent-pending CoronaLux™ system uses a low-energy, plasma-enhanced pyrolytic process to safely and reliably destroy hazardous, chemical, biological (military de-weaponization), pharmaceutical, and regulated medical waste.

Pertaining to Industrial/Environmental solutions, SENR’s solutions portfolio includes services for environmental regulation and compliance, upstream/downstream oil and gas operations, wastewater treatment, dewatering/centrifuging, railcar and tank cleaning, and general waste handling and minimization services.

Regarding Odor/Emissions Control & Renewable Fuels, SENR’s MV Technologies is an engineering/technology business. MV designs and provides odor, vapor, and emission control systems for various sectors.

This past November, SENR announced that its majority-owned subsidiary, Paragon Waste Solutions, in association with its California partner, received final air quality permit approval from South Coast Air Quality Management District 'SCAQMD' in California for its CoronaLux Waste Destruction System.

In December, SENR announced that its majority-owned subsidiary, Paragon Waste Solutions, closed its joint venture (JV) agreement with GulfWest Waste Solutions. The new entity will be named Paragon Southwest Medical Waste, LLC (PSMW). It will have an exclusive license to the CoronaLux™ technology in a six-state area of the Southern U.S.

Paragon Waste Solutions will also be the operating partner for the business and sell several additional systems to the JV over the next five years. GulfWest Waste Solutions is owner and operator of one of the nation's few permitted medical waste incinerators located in Anahuac, Texas.

Last week, SENR announced that Paragon Waste Solutions completed the commissioning and start-up of Paragon Southwest Medical Waste, LLC (PSMW), a waste destruction facility in Anahuac, Texas. The initial loads of medical waste have been processed.

The facility now represents the first-time "bypass" medical waste can be destroyed in the U.S. on a large-scale, commercial basis in a way other than traditional incineration. PSMW is already permitted to be much larger than SENR’S present JV facility in Southern California.

Strategic Environmental & Energy Resources, Inc. (SENR), closed Tuesday's trading session at $0.49, down 8.92%, on 7,865 volume with 7 trades. The average volume for the last 60 days is 26,987 and the stock's 52-week low/high is $0.40/$1.08.


The QualityStocks
Company Corner


PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.4199, up 23.21%, on 14,713,216 volume with 3,155 trades. The stock’s average daily volume over the past 60 days is 14,326,094, and its 52-week low/high is $0.0006/$0.957.

PotNetwork Holding, Inc. (OTC Pink:POTN) today announced that its subsidiary, Diamond CBD, Inc. has co-sponsored the first in a series of planned charity events in Southeast Asia. The event targeted 100+ at-risk youth and children in a poor neighborhood in the city of Manila, Philippines. Hundreds of food items (canned goods, milk, biscuits, rice, meatloaf...) as well as critical supplies (soap, shirts, blankets) were delivered to our Lady of Lourdes Chapel located at 1 Kambal Rd, Guitnang Bayan 2, San Mateo, 1850 Rizal, Philippines.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

PotNetwork Holding's Diamond CBD and XPO2 Unite For First Charity Drive in Manila, Philippines

PotNetwork Holding’s Diamond CBD Signs Exclusive Global Affinity Marketing Agreement with Exponential, Inc.

PotNetwork Holding Inc. Generates Over $3,000,000 in Sales Over First 45 days of 2018

Reign Sapphire Corp. (RGNP)

The QualityStocks Daily Newsletter would like to spotlight Reign Sapphire Corp. (RGNP). Today, Reign Sapphire Corp. closed trading at $0.125, up 11.61%, on 113,566 volume with 15 trades. The stock’s average daily volume over the past 60 days is 64,041, and its 52-week low/high is $0.0519/$0.325.

Direct-to-consumer, conflict-free, custom and branded jewelry company Reign Sapphire Corp. (OTCQB: RGNP) was originally established to leverage a ‘source-to-retail’ model for fine Australian sapphires. Utilizing a transparent, mine-to-market supply chain, Reign sapphires are guaranteed natural gems of certified origin, manufactured under guaranteed ethical and sustainable processes.

Reign Sapphire Corp. (RGNP), is a direct-to-consumer, custom and branded jewelry company headquartered in Los Angeles, California. Reign's mission is to provide ethical and sustainable jewelry direct to the modern consumer, marketed through sophisticated digital initiatives that speak directly to individuals through social media channels and personalized promotions. The company's lean operating model ensures expenses are linked to order flow with flexible production schedules targeting just-in-time delivery, which in turn reduces or eliminates commodity risk. Reign is a member of the American Gem Trading Association, which is committed to fair trade and processing of gemstones.

Reign Sapphire Corp. owns and operates three divisions: Reign Brands, Reign Ventures and Reign Blockchain. Reign Brands features four unique, niche jewelry brands with separate social media followings:

  • Reign Sapphires: Ethically produced, millennial-targeted sapphire jewelry sourced from Australia.
  • Coordinates Collection: Custom jewelry inscribed with location coordinates commemorating life's special moments.
  • Le Bloc: Classic, customized jewelry.
  • ION Collection by Jen Selter: Athleisure jewelry brand.

Reign Ventures is the company's joint venture platform for investment and development of jewelry technology-related products.

Reign Blockchain authenticates its sapphires as conflict-free, allowing customers to wear products created by a company that shares their beliefs in human dignity and environmental stewardship. In 2018, Reign Blockchain is preparing to conduct an initial coin offering (ICO) for ReignCoin, subject to regulatory approval. ReignCoin will serve as Reign's cryptocurrency as part of a blockchain-based loyalty reward program.

The company's products are sold through a commission-based affiliate program that is supported by personalized email campaigns and promotions, celebrity promotion and gifting, digital advertising based on keyword purchases and sponsored ads, and creative publicity events and media outreach to attract maximum exposure. The successful launch of a company-wide social media influencer campaign across all its retail brands boosted Reign's Instagram, Twitter and Facebook followings by double digits within the first three weeks of going live.

Reign continues to seek out international partnerships, adding to the success it has already achieved in the Middle East, where its flagship store is in the Dubai Mall. The company recently teamed up with the original founder of its Coordinates Collection brand, Owen de Vries, who will lead its Europe and United Kingdom sales efforts. The Netherlands-based operation will proliferate Reign point-of-sales that are adapted for local language, digital marketing and customer service.

Reign Sapphire Corp. is led by president and CEO Joseph Segelman, who has also served on the board of directors since December 2014. Segelman earlier served as the Chief Executive Officer and managing director of Australian Sapphire Corporation, Shefa Mining Corporation and Spencer Lloyd & Associates. He is an experienced marketing and operations professional with over 20 years of experience in logistics and marketing, and extensive experience in the Australian mining and gem industry. He is also a director and board member of OBK (a Sydney, Australia, based charity) and a Captain (Chaplain) in the Australian Army reserves. Segelman is the author of "Take Action: Successful Australians Share their Secrets." (Lothian Books, 2004).

The company's board of advisors includes Andrea Hansen, jewelry marketing veteran and former president of the Women's Jewelry Association; Jeremy Avitan, CPA and compliance executive; Michael Lawrence corporate lawyer and litigator, Doug Cole, corporate financier and entrepreneur, Thierry Chaunu, a luxury goods executive with prior senior management roles at Chopard, Christofle and Cartier, and Pinny Gwinisch, founder of Ice.com and adjunct professor at McGill and Rutgers University. Disclaimer

Reign Sapphire Corp. Company Blog

Reign Sapphire Corp. News:

Reign Sapphire Corp. (RGNP) – Custom Jewelry for Millennials

NetworkNewsBreaks – Reign Sapphire Corp. (RGNP) to Launch Sapphire-backed Cryptocurrency

Reign Sapphire Corp. (RGNP) Offering Custom-Made Jewelry that’s Memorable and Conflict-Free

Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG). Today, Medical Cannabis Payment Solutions closed trading at $0.04, up 10.50%, on 403,411 volume with 41 trades. The stock’s average daily volume over the past 60 days is 660,633, and its 52-week low/high is $0.0161/$0.12.

Medical Cannabis Payment Solutions (OTC: REFG) boasts an industry first. Through a state-of-the-art financial services system that is easy to set up and simple to use, the company’s solution to cannabis banking has shown how to solve cash-handling issues, offering electronic payment and e-commerce features. This gives the marijuana business direct and immediate access to funds while still complying with all federal (FinCEN) laws aimed at combatting both domestic and international money laundering and terrorist financing, among other financial crimes.

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company's state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company's unique "StateSourced" proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven't been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin's cryptocurrency ($Weed) with Medical Cannabis Payment Solutions' StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

"We've completed our transition from development stage to revenue stage," says Roberts. "We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases."

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry. Disclaimer

Medical Cannabis Payment Solutions Company Blog

Medical Cannabis Payment Solutions News:

Medical Cannabis Payment Solutions (REFG) Sidesteps Bottlenecking of Cash Transactions through Innovative Platform

CannabisNewsBreaks – Medical Cannabis Payment Solutions (REFG) CEO Believes Proposed Legislation on Medical Marijuana in Utah Will be a Success

Medical Cannabis Payment Solutions (REFG) Helps Fill State Coffers

AnalytixInsight Inc. (TSX.V:ALY) (OTCQB:ATIXF)

The QualityStocks Daily Newsletter would like to spotlight AnalytixInsight Inc. (ATIXF). Today, AnalytixInsight Inc. closed trading at $0.383, up 9.43%, on 3,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 34,299 and its 52-week low/high is $0.15/$0.6898.

Artificial intelligence company AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) plans to integrate Marketwall, a real-time stock trading app, into a banking group’s trading platform. An article discussing the company reads: “AnalytixInsight plans to integrate its 49 percent-owned fintech subsidiary’s real-time stock trading app, Marketwall, into Italy-based banking group Intesa Sanpaolo during 2018. This will give ATIXF exposure to the group’s eight million stock-trading clients (http://nnw.fm/uv4Bs).

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence (AI) company that transforms data into knowledge. The company has developed a proprietary, machine-learning technology that algorithmically analyzes big data and distills it into actionable insights. AnalytixInsight has strategic initiatives in fintech, blockchain and workflow analytics, and its technology is scalable and extendable to virtually any data-driven industry such as sports, communications, healthcare, insurance or government.

The company's flagship product – CapitalCube.com – is a financial portal providing comprehensive company analysis including on-demand fundamental research, portfolio evaluation and screening tools on over 50,000 global equities and North American ETFs. CapitalCube's online portal is designed to empower investment ideas by providing in-depth analysis, peer-to-peer performance evaluations, accounting and earnings reports, dividend strength and AI-supported information about likely corporate actions such as dividend changes, share buybacks and acquisitions. AnalytixInsight provides a robust technology that is frequently rebalanced to maintain a desired risk profile, matching risk to ideal ETF exposure, with regular compliance reporting.

CapitalCube's freemium pricing model allows free access to basic financial information, with additional in-depth analysis and predictive analytics provided at a rate of $25 per month, and customized peer analysis for $300 per month. CapitalCube publishes 3,000 articles daily and has multi-language capabilities. Thomson Reuters and Africa Investor have recently been added to the growing network of content partnerships that already includes Euronext NV, Yahoo Finance and The Wall Street Journal.

Euclides Technologies is a subsidiary company focused on Field Service Management software solutions, led by a team with decades of experience in developing and implementing workforce management solutions for large global corporations. With worldwide customers representing over 100,000 field service personnel across multiple industries, Euclides Technologies has a deep understanding of the increasing amount of data generated within the industry, as well as the analytics solution offerings to transform that data into knowledge.

MarketWall is a Fintech subsidiary that develops integrated software solutions as part of an ecosystem of smart devices that includes PCs, tablets, smart phones, wearable mobile devices and Smart TV. AnalytixInsight Inc. has joint ownership in MarketWall together with Intesa Sanpaolo, Italy's largest retail bank which has over 4,000 branches and a market capitalization of $40 billion Euros. MarketWall is expected to deploy its real-time stock trading and mobile banking app to Intesa Sanpaolo's 12.6 million customers in six European countries during 2018. The mobile stock trading application will directly interface with Intesa Sanpaolo's established MarketHub trading platform. As a Samsung Global Partner, the MarketWall app is preloaded in mobile devices in certain areas in Europe.

AnalytixInsight is currently evaluating and pursuing Blockchain initiatives which are contiguous with its artificial intelligence platform, to use a distributed ledger technology to reduce transaction costs and settlement times for its users, partners, and subsidiaries. The Company believes these initiatives will enhance current revenues being received from existing multi-year agreements with its partners. Disclaimer

AnalytixInsight Inc. Blog

AnalytixInsight Inc. News:

NetworkNewsBreaks – AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) to Reach Traders in Six Countries through Real-time Trading App

Is Artificial Intelligence Pioneer AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Undervalued?

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Plans 2018 Rollout of Stock Trading App

Petroteq Energy Inc. (TSX.V:PQE) (OTCQX:PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF). Today, Petroteq Energy Inc. closed trading at $1.4153, up 7.22%, on 475,944 volume with 704 trades. The stock’s average daily volume over the past 60 days is 65,102, and its 52-week low/high is $0.015/$1.8892.

Petroteq Energy Inc. (TSXV: PQE; OTCQX: PQEFF; Frankfurt: A2DYWC), a company focused on the development and implementation of proprietary technologies for the energy industry, today announced that it has successfully completed testing of all major process systems at its heavy oil extraction facility in Asphalt Ridge, Utah. Further, the Company has initiated test runs of the utility system—among the final steps prior to launching commercial production.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQB: PQEFF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

Petroteq Energy Inc. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, Petroteq Energy Inc. and its mining interests are primed for success.

Petroteq Energy Inc. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

Petroteq Energy Inc. Company Blog

Petroteq Energy Inc. News:

Petroteq Energy Announces Offtake Agreement With Firebird Logistics for 100% of Production From Its Utah Heavy Oil Extraction Facility

Petroteq Energy Announces Completion of All Major Process Systems at Its Utah Heavy Oil Extraction Facility

Petroteq Energy Announces Proposed Issuances of Securities

MGX Minerals Inc. (MGXMF)

The QualityStocks Daily Newsletter would like to spotlight MGX Minerals Inc. (MGXMF). Today, MGX Minerals Inc. closed trading at $1.119, up 3.93%, on 184,974 volume with 124 trades. The stock’s average daily volume over the past 60 days is 289,591 and its 52-week low/high is $0.543/$1.5835.

MGX Minerals Inc. (CSE:XMG) (FKT:1MG) (OTC:MGXMF) is pleased to report results of an independent technical report prepared in accordance with CIM guidelines and National Instrument 43-101 definition of a Preliminary Economic Assessment ("PEA") on its Driftwood Creek Magnesium Project (“Driftwood Creek” or the “Project”).

MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) is a diversified Canadian resource company developing large-scale mineral portfolios in specific commodities and jurisdictions in North America. The company controls significant interest in lithium, magnesium and silicon assets that offer streamlined development timelines and low capital expenditures. MGX Minerals and its engineering partner have developed a patent-pending, low-energy design process to extract valuable minerals from the abundant, highly mineralized brine wastewater produced each year by oil and gas companies.

This proprietary, petrolithium process rapidly concentrates lithium and other minerals from brine in less than a day. That's a stunning advancement from the conventional method of extracting minerals from brine through an evaporation process that can take up to 18 months, requires hundreds of acres of land, and averages less than a 50 percent mineral recovery rate. Using this advanced water purification technology, MGX Minerals cleans the wastewater that accompanies petroleum as it's being pulled up to the surface. The company's petrolithium process eliminates the need to inject contaminated wastewater back into the ground, which prevents drinking water contamination and possible earthquakes.

In January 2017, MGX Minerals successfully recovered concentrated lithium from heavy oil evaporator blowdown wastewater using its rapid recovery process, an accomplishment independently confirmed by the Saskatchewan Research Council. In August 2017, the company also successfully processed wastewater and lithium brine from eight North American projects at its one-cubic-meter-per-hour processing plant, proving the technology is economically viable. Research group Global Water Intelligence expects the wastewater treatment industry to grow into a $45 billion market annually by 2025, which suggests there are ample revenue-generating opportunities for MGX Minerals technology.

Lithium, the "white gold" of the new energy economy, is the key to clean energy development as global demand for hybrid and electric vehicles, high-drain portable electronic devices, and large-scale energy storage systems ramps up. Grand View Research, Inc. reports that the global lithium-ion battery market is expected to reach $93.1 billion by 2025. Current market forces show a high demand for lithium and a low supply, which further supports the necessity of MGX Mineral's cleaner, faster method of extracting high-value minerals from brine wastewater.

MGX Minerals is led by a team of industry standout performers who have worked in the mining and technology industries for decades. The leadership team is joined by an array of top-notch technical partners with unmatched experience in the oil and gas sectors, environmental services industry, marketing and product development, along with applied research and commercial development of technologies. Disclaimer

MGX Minerals Inc. Blog

MGX Minerals Inc. News:

MGX Minerals Announces Positive PEA for Driftwood Creek Magnesium; Pre-Tax NPV of C$529.8 Million and 24.5% IRR

MGX Minerals to Proceed with Hydrogen Gasification and Battery Metals Extraction from Petroleum Coke; Receives Initial Vanadium Nickel Cobalt Assay Results

MGX Minerals Announces Completion of 3,000 Metre Drill Program at Case Lake Lithium; 8,000 Metre Spring Drill Program Planned

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $1.36, up 1.49%, on 160,018 volume with 238 trades. The stock’s average daily volume over the past 60 days is 435,357 and its 52-week low/high is $0.27/$2.54.

American smokers are stubbing out their cigarettes. Data from the Centers for Disease Control and Prevention (CDC) show that the proportion of the adult American population that has smoked at least 100 cigarettes during their lifetimes stood at 15.5 percent in 2016, down from 20.9 percent in 2005. As a result, alternative delivery biotechnologies for nicotine have become a recent R&D focus for cigarette manufacturers and other companies, including Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP).

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

Smokers Light Up Less, Alternative Nicotine Delivery Technologies Take Center Stage

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Seven-Year Licensing Agreement with Cannfections Group, Inc.

NetworkNewsAudio Covers Global Licensing Agreement of Lexaria Bioscience Corp. (CSE:LXX) (OTCQX:LXRP) and NeutriSci International Inc. (TXS-V:NU) (OTCQB:NRXCF)


The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF). Today, ABcann Global closed trading at $1.66, off by 3.49%, on 356,748 volume with 548 trades. The stock’s average daily volume over the past 60 days is 789,459 and its 52-week low/high is $0.6171/$3.2929.

ABcann Global (TSX.V:ABCN) (OTCQB:ABCCF) is pleased to provide the following business update. “Over the past five months we have enhanced our leadership team, strengthened our balance sheet, improved operational effectiveness and executed a strategic acquisition.  Last week, after completing an extensive strategic review of our operations and growth plans, our board of directors approved our 2018 Business Plan, and the ABcann team is now sharply focused on execution,” stated Barry Fishman, Chief Executive Officer.

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) ABcann Medicinals, Inc. is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. One of the earliest licensed Canadian medical marijuana producers under Canada's federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space. The company currently owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario. Additionally, ABcann owns 65 acres of real estate with proper zoning and existing infrastructure in place to support the construction of another production facility of up to one million square feet.

In a November 2016 report, market research firm Canaccord Genuity Group forecasted that the medical marijuana market in Canada could see sales in excess of $8 billion by 2024, creating a sizable opportunity for the country's licensed producers (LPs). The research firm also noted that the "rigorous process of becoming a licensed producer of cannabis in Canada imposes significant barriers to entry and there will be a shortfall of supply in a legalized market in the short-term." This market barrier serves as a strategic advantage for ABcann as it prepares for its highly-anticipated IPO, which is currently scheduled for April 2017.

Canaccord's synopsis of the Canadian cannabis industry is supported by recent market activity, as companies sporting one of the illustrious Canadian government licenses for medicinal production have recorded strong growth following IPO. Canopy Growth (OTC: TWMJ), one of the largest fully-licensed Canadian marijuana growers, saw share prices skyrocket by more than 700 percent in the months following its initial offering. Aphria Inc. (OTC: APHQF), another licensed grower, climbed by more than 900 percent following its IPO. Other companies that have recorded huge growth since going public include Aurora Cannabis (OTC: ACBFF), climbing nearly 900 percent, and SupremePharma (OTC: SPRWF), which soared more than 1,300 percent.

With these market trends in mind, ABcann's impending IPO is one that prospective investors in the marijuana sector will want to explore. Recalls from some of the biggest players in the Canadian cannabis industry have highlighted the considerable learning curve that LPs face in today's market, which makes ABcann's proven track record in the market all the more noteworthy. The company has built a reputation over the years for its best-in-class standardized approach to growing cannabis, including the thoughtful omission of pesticides and a computer monitored growing technique that allows ABcann to minimize the risks of variance in its yields and ensure the creation of consistently high-quality products.

This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann's current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry. This global growth potential is illustrated by ABcann's partnership with Israel's Syqe Medical, producer of the world's first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting the company's production facility, Perry Davidson, founder of Syqe Medical, noted that ABcann's production technologies put it "in a class with the best in the world" in its ability to produce standardized pharmaceutical grade cannabis.

ABcann's entry into the public sector is being guided by a seasoned management team, board of directors and advisory board that feature well over a century of combined industry experience. Ken Clement, the company' founder and executive chairman, has been the key component and driving force behind ABcann's development since its inception. His vision of standardized production and dosage sets ABcann apart in the medical cannabis sector. Clement is joined on the company's management team by CEO Aaron Keay. Keay brings more than a decade of capital markets experience to ABcann, having played a role in raising approximately $250 million for public and private market issuers.

Notably, ABcann also has access to the 'Father of Cannabis Research', Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC), and he has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well-positioned to compete in the rapidly-expanding Canadian medicinal cannabis industry. These factors, along with the company's ongoing global expansion into the European, Australian and Israeli markets, show why ABcann Medicinals' upcoming public offering fits the bill as "Canada's Next Medical Marijuana IPO." Disclaimer

ABcann Global Blog

ABcann Global News:

ABcann Global Provides Business Update

ABcann Global Completes $70 Million Bought Deal Financing and $4.8 Million Exercise of Underwriters’ Over-Allotment Option

ABcann Global (TSX.V:ABCN) (OTCQB:ABCCF) Sees IIROC Trade Halt and Restart on the TSX-V

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0193, off by 5.85%, on 8,965,167 volume with 245 trades. The stock’s average daily volume over the past 60 days is 13,099,393, and its 52-week low/high is $0.0141/$0.16.

MoneyTrac Technology, Inc., a subsidiary of Global Payout, Inc. (OTC:GOHE),  is pleased to announce that its partner, GreenBox POS ("GBOX") will be sponsoring Nate Errez, native of San Diego, in his bid to represent the United States in Sprint Kayaking, at the 2020 Summer Olympics.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

MoneyTrac Technology Inc.'s Strategic Partner GreenBox POS, Sponsors Native San Diegan in Olympic Bid

NetworkNewsAudio Announces Audio Press Release (APR) on Global Payout, Inc. Revolutionizing Payment Processing with Blockchain

NetworkNewsWire Announces Publication on Contenders Transforming Payment Processing with Blockchain

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.002, off by 20.00%, on 387,000 volume with 6 trades. The stock’s average daily volume over the past 60 days is 1,119,374, and its 52-week low/high is $0.0005/$0.0085.

Consorteum Holdings, Inc. (OTC:CSRH), a software development company and mobile device solutions provider, today announced that its subsidiary, 359 Mobile UK Limited, has retained London based legal firm Joelson JD LLP (“Joelson”) as its legal adviser as it expands into UK and European markets.

Consorteum Holdings, Inc. (CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company's commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.

Consorteum Holdings, utilizing its Universal Mobile Interface™ ("UMI") solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company's UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.

Led by the development team at Consorteum's wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company's UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI's technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.

Consorteum's primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum's management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.

Consorteum's management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.

Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings, Inc. Retains Joelson JD, LLP for Legal Representation and Advice on Upcoming UK Gaming Initiatives

Consorteum Holdings, Inc. (CSRH) Builds on Partnerships, Platform to Enable Mobile Industries

Consorteum Holdings, Inc. Announces Joint Business Agreement with DevLex Ltd.


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Trader Power News
(AMTX) +65.09%


(SHRV) +44.24%


(FRLF) +42.77%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251